Distribution (percentage) of 785 SNs among 724 patients, by reporting source. Includes solid SNs excluding NMSC and other/unknown neoplasms diagnosed after the first HCT and before the end of follow-up (defined as the earliest occurrence of a second HCT, death, last known alive status from either CCR or CIBMTR, or the study end date [31 December 2018]). Other and unknown race includes Native Hawaiian and other Pacific Islander and American Indian/Alaska Native patients. For each patient, a maximum of 1 SN per type is counted, but patients with multiple SNs can contribute to >1 SN type. For SNs reported by both sources, date of SN and interval between HCT and SN are based on the earlier reported SN (if dates differed between CCR and CIBMTR). For confidentiality, row percentages were suppressed if any cells had <5 SNs. CA, California; NHB, non-Hispanic Black; NHW, non-Hispanic White.